Celgene Corp. (CELG)
The income statement (statement of earnings) reports on the performance of Celgene Corp., the result of its operating activities.
The assets reports major classes and amounts of resources owned or controlled by Celgene Corp..
The liabilities and stockholders’ equity reports major classes and amounts of external claims on assets and owners’ capital contributions, and other internally generated sources of capital.
The cash flow statement provides information about Celgene Corp.’s cash receipts and cash payments during an accounting period, showing how these cash flaws link the ending cash balance to the beginning balance shown on Celgene Corp.’s balance sheet.
Common-Size Financial Statements
Income statement components (revenues and expenses) shown as percentage of total sales.
Assets components shown as percentage of total assets.
Liabilities and stockholders’ equity components shown as percentage of total liabilities and stockholders’ equity.
Evaluates revenues and output generated by the Celgene Corp.’s assets. Operating performance ratios describe the relationship between the Celgene Corp.’s level of operations and the assets needed to sustain operating activities.
Measures how efficiently Celgene Corp. generates revenues from its investments in fixed or total assets.
Measures the adequacy of a Celgene Corp.’s cash resources to meet its near-term cash obligations.
Examines Celgene Corp.’s capital structure in terms of the mix of its financing sources and the ability of the firm to satisfy its longer-term debt and investment obligations.
Measures the income of Celgene Corp. relative to its revenues and invested capital.
An approach to decomposing Celgene Corp.’s return on equity as the product of other financial ratios.
Relative valuation technique determine the value of Celgene Corp. by comparing it to similar entities (like industry or sector) on the basis of several relative ratios that compare its stock price to relevant variables that affect the stock’s value, such as earnings, book value, and sales.